Carregant...
PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression
The therapy of different advanced-stage malignancies with monoclonal antibodies blocking programmed cell death protein 1 (PD-1)/PD-1 ligand 1 (PD-L1) signaling has had an impressive long-lasting effect in a portion of patients, but in most cases, this therapy was not successful, or a secondary resis...
Guardat en:
| Publicat a: | Int J Mol Sci |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486151/ https://ncbi.nlm.nih.gov/pubmed/28635644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18061331 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|